# DEFLAZACORT
> **ANDA217813** · Abbreviated New Drug Application (Generic) · Sponsor: TRIS PHARMA INC · Approved 2024-04-25
## Drug
- **FDA Application Number:** ANDA217813
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DEFLAZACORT
- **Generic name:** DEFLAZACORT ORAL
- **Active ingredients:** DEFLAZACORT
- **Dosage form:** SUSPENSION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** TRIS PHARMA INC
- **Manufacturer:** Cranbury Pharmaceuticals, LLC
- **First approval:** 2024-04-25
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217813)
---
*AI Analytics · CC0 1.0*